Birte Wistinghausen
Expertise in
5
conditions
Expertise in
5
conditions
9850 Key West Avenue, 
Rockville, MD 

Overview

Birte Wistinghausen, MD, is a pediatric oncologist and member of the leukemia and lymphoma team. She treats children, adolescents and young adults with non-Hodgkin lymphoma (NHL), histiocytosis and leukemia. Her clinical research concentrates on non-Hodgkin lymphoma, specifically on the role of Epstein-Barr virus (EBV) in Post-Transplant Lymphoproliferative Syndrome (PTLD) and cellular therapy in EBV-positive PTLD as well as the biology and treatment of B-lymphoblastic lymphoma. Dr. Wistinghausen's roles within the Children’s Oncology Group (COG) include serving as the principal co-investigator of a clinical study using EBV-specific T-cells in patients with post-transplant lymphoproliferative disease and being the responsible investigator for B-lymphoblastic lymphoma. She is also serving as vice-chair for education of the COG NHL committee.

Dr. Wistinghausen is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Histiocytosis, and Reticulohistiocytoma.

Dr. Wistinghausen is board certified in American Board Of Pediatrics, 2002. She is actively involved in clinical research, co-authoring 28 peer reviewed articles and participating in 20 clinical trials.

Graduate Institution

Christian-Albrechts Universitaet Zu Kiel, 1993

Residency

New York University School of Medicine, Pediatrics - 1999

Specialties

Pediatrics

Licenses

Pediatrics in NY

Board Certifications

American Board Of Pediatrics, 2002

Fellowships

New York University School of Medicine, Hematology & Oncology - 2001

Languages Spoken

English
German

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 7 Less Insurance Carriers -

Locations

Montgomery County
9850 Key West Avenue, Rockville, MD 20850
Other Locations
Telehealth Video Visit
111 Michigan Avenue Northwest, Childrens National Telemedicine, Washington, DC 20010
Main Hospital-Cancer and Blood Disorders Clinic
111 Michigan Avenue Northwest, Washington, DC 20010

Additional Areas of Focus

Dr. Wistinghausen has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


20 Clinical Trials

A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
View 9 Less Clinical Trials
Similar Doctors
Expertise in
15
conditions
Pediatrics
Expertise in
15
conditions
Pediatrics
Referral may be required

Ozlem Goker-Alpan MD LLC

3702 Pender Dr Ste 170, 
Fairfax, VA 
 (223.3 miles away)
Languages Spoken:
English

Ozlem Goker is a primary care provider, practicing in Pediatrics in Fairfax, Virginia. Dr. Goker is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Gaucher Disease, Fabry Disease, Gaucher Disease Type 1, and Pompe Disease.

Expertise in
30
conditions
Pediatrics
Expertise in
30
conditions
Pediatrics
Referral may be required

Children's National Hospital

111 Michigan Ave NW, 
Washington, DC 
 (207.3 miles away)
Languages Spoken:
English

Roger Packer is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Packer is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Gliomatosis Cerebri.

Expertise in
37
conditions
Expertise in
37
conditions
Referral may be required

Children's National Hospital

111 Michigan Ave NW, 
Washington, DC 
 (207.3 miles away)
Languages Spoken:
English

Andrea Gropman is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Gropman is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses Klinefelter Syndrome, Urea Cycle Disorders (UCD), MELAS Syndrome, Ornithine Transcarbamylase Deficiency, and Hormone Replacement Therapy (HRT).

Frequently Asked Questions about Dr. Birte Wistinghausen

How do I make an appointment with Dr. Birte Wistinghausen?

You can book an appointment with Dr. Birte Wistinghausen by calling their office at 301-765-5400. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Birte Wistinghausen a top-rated expert for Acute Lymphoblastic Leukemia (ALL)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Birte Wistinghausen is classified as an Advanced expert for Acute Lymphoblastic Leukemia (ALL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Birte Wistinghausen specialize in?

While Dr. Birte Wistinghausen is a Pediatrics, they have specific expertise in Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, and Histiocytosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Birte Wistinghausen participate in research or clinical trials?

Yes. Dr. Birte Wistinghausen has published 28 articles and abstracts on conditions like Acute Lymphoblastic Leukemia (ALL). You can view a list of Dr. Birte Wistinghausen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Birte Wistinghausen accept my insurance?

Dr. Birte Wistinghausen accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 301-765-5400 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wistinghausen's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile